Researchers track Long-Term safety of experimental eye cancer treatment
NCT ID NCT07338968
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a long-term follow-up for 100 people who completed a previous trial of bel-sar, an experimental treatment for early choroidal melanoma (a type of eye cancer). Participants will not receive any new treatment but will be monitored for about 5 more years to check for side effects and see how they are doing. The goal is to gather safety data over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New proton therapy aims to save eyes from removal in large melanoma cases
- Researchers track Long-Term safety of experimental eye cancer drug
- How does eye cancer treatment affect daily life? new study aims to find out
- New combo therapy aims to shrink eye tumors before radiation
- New eye injection could spare sight in melanoma patients
- New hope: eye injections may stop Radiation-Related blindness